GAB2 and liver cancer: MTT assays demonstrated that Gab2 overexpression still promoted liver cancer cell growth, as previously described (Fig. 4A, red line compared with blue line), but Gab2 deletion dramatically restrained HepG2 cell growth (Fig. 4B, blue line compared with red line).